Company intelligence / Profile preview

Seventeen Pharma

La Tour-de-Peilz, Vaud, Switzerlanddnb.com ↗

Ownership: Private
Development stage: Other

Overview

Seventeen Pharma is a Swiss consulting firm founded by Alain Coppex in 2015, specializing in helping biotech and pharma companies commercialize orphan drugs for rare diseases in Switzerland. The company offers strategic guidance and operational support from pre-market approval through post-launch phases, aiming to accelerate patient access to new therapies within the Swiss healthcare system. It does not develop its own drugs.

Therapeutic areas: Rare Diseases
Modalities: Orphan drugs (all modalities via clients)
Industry: Consulting

Beyond the preview

Go deeper on Seventeen Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seventeen Pharma.

Explore the full profile